Nordic Market Entry with Scalable Cross-Functional Support

Client situation

The client was a large Asian life science company with an established presence in selected European markets. The company wanted to establish its first Nordic presence in Denmark, with a local office in Copenhagen connected to its existing European organisation. The ambition was to start with a lean Danish setup and gradually expand into the other Nordic markets as the business developed.

Client challenge

The client needed to establish a compliant and efficient Nordic foundation before launching and scaling its commercial operations. The initial focus was on understanding the regulatory requirements, preparing for market entry and establishing the necessary local compliance infrastructure. At the same time, the client wanted to avoid building a large, fixed organisation too early. As the business progressed, it would need access to local expertise across Regulatory, Market Access, QA and PV, as well as recruitment and interim support to build the commercial organisation and gradually establish its own Nordic capabilities.

PharmaRelations’ solution

PharmaRelations provided a stepwise Nordic market entry model, starting with Regulatory and compliance and gradually expanding into Market Access, QA, PV, recruitment and commercial support. The initial phase focused on the Danish market, including regulatory strategy, market entry planning, local requirements and the establishment of the necessary quality and pharmacovigilance infrastructure. PharmaRelations also supported Market Access activities, including pricing and reimbursement considerations.

As the client moved closer to commercial launch, PharmaRelations supported the build-up of the local organisation through recruitment, interim resources and commercial expertise. This enabled the client to establish the first local roles while maintaining flexibility and avoiding a large, fixed organisation from day one. Once the Danish setup was established, the same cross-functional model could be scaled to additional Nordic markets, combining local country expertise with a coordinated Nordic approach.

Implementation approach

The implementation followed a phased approach:

Phase 1 – Regulatory, Market Access & Compliance Set-up

Regulatory strategy, dossier due diligence and Nordic launch planning, starting with Denmark.
Marketing authorization activities, local product information, translations and submission support.
Market Access assessment, including pricing and reimbursement strategy and launch sequencing.
QA set-up, including QMS, SOPs, training, supplier qualification and audit readiness.
PV set-up, including local safety processes, local contacts and safety activities.
Establishment of the local roles and governance needed to support the Nordic launch.

Phase 2 – Commercial Launch & Organisation Build

Development of the commercial launch plan and Nordic operating model.
Interim commercial, sales, marketing and medical support as required.
Recruitment of the first local employees and specialists.
Executive Search and specialist recruitment across the Nordic markets.
Use of interim and try-and-hire solutions to test and scale the organisation.
Gradual expansion from Denmark into additional Nordic markets based on launch plans and business needs.

Outcome for the client

The client was able to establish a local Nordic presence in Denmark with a controlled and scalable approach, starting with the regulatory and compliance foundation before building the commercial organisation. The model provided access to the required Nordic expertise without the need to establish all functions internally from the beginning. As the business developed, PharmaRelations could support the transition from regulatory and compliance activities into commercial launch, recruitment and organisation building. The approach also created a platform that could be extended to other Nordic countries, allowing the client to scale its presence in line with regulatory approvals, market access milestones and commercial needs.

Faster and more structured market entry
Reduced market-entry risk and fixed organizational commitment
Access to cross-functional Nordic expertise
Flexible transition from outsourced/interim support to internal capabilities
Scalable model for expansion across the Nordic markets

Key success factors

Regulatory-first approach to establish the foundation for Nordic market entry.
Strong local knowledge of Danish and wider Nordic regulatory and market access requirements.
Cross-functional support across Regulatory, Market Access, QA and PV.
Recruitment and interim solutions introduced as the commercial organisation was built.
Flexible model allowing the client to test and scale its Nordic organisation.
One coordinated partner supporting the transition from market entry to commercial launch and further Nordic expansion.

What this case demonstrates

This case demonstrates PharmaRelations’ ability to support international life science companies throughout the journey from Nordic market entry to commercial organization build-up. By combining Regulatory, Market Access, QA, PV, recruitment, consultancy resources and commercial expertise, PharmaRelations can provide a flexible and scalable model that starts with a compliance foundation in Denmark and expands with the client across the Nordic markets.

“PharmaRelations became an extension of our organisation in the Nordics. Their combination of local market knowledge, cross-functional expertise and flexible resources gave us a strong foundation in Denmark and a clear path for further Nordic expansion.”